Analgesics in Colombia

Date: October 24, 2017
Pages: 20
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AFD3D2F1989EN
Leaflet:

Download PDF Leaflet

Analgesics remained the largest category in OTC in Colombia in 2017. Similar to what is being seen globally, analgesics is a fairly mature category, with steady growth being driven by the proven efficacy of well-recognised brands and the ongoing efforts of manufacturers to introduce new formulations to better treat minor ailments which interfere with daily routines. In Colombia, migraine affects around 10% of the population, or five million people, with those aged 30-45 the most affected due to...

Euromonitor International's Analgesics in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Innovation Contributes To Maintaining Positive Growth
Diclofenac Switched To OTC Status
Competitive Landscape
Competitive Landscape Remains Unchanged
New Entrants
Share of Generics and Private Label Remains Low
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Maintains Positive Growth in 2017 Amidst An Economic Slowdown
Growing Self-medication Trend Supported by Switches
Foreign Manufacturers Command A Major Share of Value Sales
Chemists/pharmacies Remains the Leading Distribution Channel for Consumer Health
Increasing Awareness of Self-care and the Ageing Population To Shape Future Sales
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Sources
  Summary 2 Research Sources
Skip to top


Calming and Sleeping in Colombia US$ 990.00 Mar, 2015 · 28 pages
Digestive Remedies in Colombia US$ 990.00 Sep, 2016 · 29 pages
Ear Care in Colombia US$ 990.00 Jul, 2013 · 25 pages
Eye Care in Colombia US$ 990.00 Sep, 2016 · 25 pages

Ask Your Question

Analgesics in Colombia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: